Tetratricopeptide-motif-mediated interaction of FANCG with recombination proteins XRCC3 and BRCA2

DNA Repair

Volumn 5, Issue 5, 2006, Pages 629-640

  Hussain, Shobbir ^a   Wilson, James B ^b   Blom, Eric ^c   Thompson, Larry H ^d   Sung, Patrick ^e   Gordon, Susan M ^f   Kupfer, Gary M ^g   Joenje, Hans ^c   Mathew, Christopher G ^a   Jones, Nigel J ^b  

^a GUY S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d LAWRENCE LIVERMORE NATIONAL LABORATORY   (United States)

^e YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f HOSPITAL FOR SICK CHILDREN   (Canada)

^g UNIVERSITY OF VIRGINIA   (United States)

Author keywords

BRCA2; FANCG; Fanconi anaemia; Homologous recombination; TPR motifs; XRCC3

Indexed keywords

BRCA2 PROTEIN; FANCONI ANEMIA GROUP G PROTEIN; PROTEIN; PROTEIN XRCC3; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BONE MARROW DEPRESSION; CANCER RISK; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CROSS LINKING; DISEASE PREDISPOSITION; FANCONI ANEMIA; GENE MUTATION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SEQUENCE HOMOLOGY; UBIQUITINATION;

AMINO ACID MOTIFS; ANIMALS; BRCA2 PROTEIN; CELL LINE; CERCOPITHECUS AETHIOPS; COS CELLS; CRICETINAE; DNA REPAIR; DNA-BINDING PROTEINS; FANCONI ANEMIA; FANCONI ANEMIA COMPLEMENTATION GROUP G PROTEIN; HELA CELLS; HUMANS; RECOMBINANT PROTEINS; RECOMBINATION, GENETIC; TWO-HYBRID SYSTEM TECHNIQUES;

CRICETINAE;

EID: 33646094490     PISSN: 15687864     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dnarep.2006.02.007     Document Type: Article

References (83)

1. Joenje H., Oostra A.B., Wijker M., diSumma F.M., vanBerkel C.G.M., Rooimans M.A., Ebell W., vanWeel M., Pronk J.C., Buchwald M., and Arwert F. Evidence for at least eight Fanconi anemia genes. Am. J. Hum. Genet. 61 (1997) 940-944
2. Thompson L.H. Unraveling the Fanconi anemia-DNA repair connection. Nat. Genet. 37 (2005) 921-922
3. Strathdee C.A., Gavish H., Shannon W.R., and Buchwald M. Cloning of cDNAs for Fanconi's anemia by functional complementation. Nature 356 (1992) 763-767
4. Levitus M., Waisfisz Q., Godthelp B.C., de Vries Y., Hussain S., Wiegant W.W., Elghalbzouri-Maghrani E., Steltenpool J., Rooimans M.A., Pals G., Arwert F., Mathew C.G., Zdzienicka M.Z., Hiom K., De Winter J.P., and Joenje H. The DNA helicase BRIP1 is defective in Fanconi anemia complementation group. J. Nat. Genet. 37 (2005) 934-935
5. Meetei A.R., Medhurst A.L., Ling C., Xue Y.T., Singh T.R., Bier P., Steltenpool J., Stone S., Dokal I., Mathew C.G., Hoatlin M., Joenje H., de Winter J.P., and Wang W.D. A human ortholog of archaeal DNA repair protein Hef is defective in Fanconi anemia complementation group M. Nat. Genet. 37 (2005) 958-963
6. Meetei A.R., de Winter J.P., Medhurst A.L., Wallisch M., Waisfisz Q., van de Vrugt H.J., Oostra A.B., Yan Z.J., Ling C., Bishop C.E., Hoatlin M.E., Joenje H., and Wang W.D. A novel ubiquitin ligase is deficient in Fanconi anemia. Nat. Genet. 35 (2003) 165-170
7. Davies A.A., Masson J.Y., McLlwraith M.J., Stasiak A.Z., Stasiak A., Venkitaraman A.R., and West S.C. Role of BRCA2 in control of the RAD51 recombination and DNA repair protein. Mol. Cell 7 (2001) 273-282
8. Pellegrini L., Yu D.S., Lo T., Anand S., Lee M., Blundell T.L., and Venkitaraman A.R. Insights into DNA recombination from the structure of a RAD51-BRCA2 complex. Nature 420 (2002) 287-293
9. Yu D.S., Sonoda E., Takeda S., Huang C.L.H., Pellegrini L., Blundell T.L., and Venkitaraman A.R. Dynamic control of Rad51 recombinase by self-association and interaction with BRCA2. Mol. Cell 12 (2003) 1029-1041
10. Wang X.Z., and D'Andrea A.D. The interplay of Fanconi anemia proteins in the DNA damage response. DNA Repair 3 (2004) 1063-1069
11. Thompson L.H., Hinz J.M., Yamada N.A., and Jones N.J. How Fanconi anemia proteins promote the four Rs: replication, recombination, repair, and recovery. Environ. Mol. Mutagen. 45 (2005) 128-142
12. Howlett N.G., Taniguchi T., Olson S., Cox B., Waisfisz Q., de Die-Smulders C., Persky N., Grompe M., Joenje H., Pals G., Ikeda H., Fox E.A., and D'Andrea A.D. Biallelic inactivation of BRCA2 in Fanconi anemia. Science 297 (2002) 606-609
13. Hussain S., Witt E., Huber P.A.J., Medhurst A.L., Ashworth A., and Mathew C.G. Direct interaction of the Fanconi anaemia protein FANCG with BRCA2/FANCD1. Hum. Mol. Genet. 12 (2003) 2503-2510
14. Hussain S., Wilson J.B., Medhurst A.L., Hejna J., Witt E., Ananth S., Davies A., Masson J.Y., Moses R., West S.C., de Winter J.P., Ashworth A., Jones N.J., and Mathew C.G. Direct interaction of FANCD2 with BRCA2 in DNA damage response pathways. Hum. Mol. Genet. 13 (2004) 1241-1248
15. Wang X.Z., Andreassen P.R., and D'Andrea A.D. Functional interaction of monoubiquitinated FANCD2 and BRCA2/FANCD1 in chromatin. Mol. Cell. Biol. 24 (2004) 5850-5862
16. Taniguchi T., Garcia-Higuera I., Andreassen P.R., Gregory R.C., Grompe M., and D'Andrea A.D. S-phase-specific interaction of the Fanconi anemia protein, FANCD2, with BRCA1 and RAD51. Blood 100 (2002) 2414-2420
17. Yamamoto K., Ishiai M., Matsushita N., Arakawa H., Lamerdin J.E., Buerstedde J.M., Tanimoto M., Harada M., Thompson L.H., and Takata M. Fanconi anemia FANCG protein in mitigating radiation- and enzyme-induced DNA double-strand breaks by homologous recombination in vertebrate cells. Mol. Cell. Biol. 23 (2003) 5421-5430
18. Niedzwiedz W., Mosedale G., Johnson M., Ong C.Y., Pace P., and Patel K.J. The Fanconi anaemia gene FANCC promotes homologous recombination and error-prone DNA repair. Mol. Cell 15 (2004) 607-620
19. Houghtaling S., Timmers C., Noll M., Finegold M.J., Jones S.N., Meyn M.S., and Grompe M. Epithelial cancer in Fanconi anemia complementation group D2 (FancD2) knockout mice. Genes Dev. 17 (2003) 2021-2035
20. Wong J.C.Y., Alon N., McKerlie C., Huang J.R., Meyn M.S., and Buchwald M. Targeted disruption of exons 1-6 of the Fanconi Anemia group A gene leads to growth retardation, strain-specific microphthalmia, meiotic defects and primordial germ cell hypoplasia. Hum. Mol. Gene. 12 (2003) 2063-2076
21. Ohashi A., Zdzienicka M.Z., Chen J.J., and Couch F.J. Fanconi anemia complementation group D2 (FANCD2) functions independently of BRCA2- and RAD51-associated homologous recombination in response to DNA damage. J. Biol. Chem. 280 (2005) 14877-14883
22. Nakanishi K., Yang Y.G., Pierce A.J., Taniguchi T., Digweed M., D'Andrea A.D., Wang Z.Q., and Jasin M. Human Fanconi anemia monoubiquitination pathway promotes homologous DNA repair. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 1110-1115
23. Yang Y.G., Herceg Z., Nakanishi K., Demuth I., Piccoli C., Michelon J., Hildebrand G., Jasin M., Digweed M., and Wang Z.Q. The Fanconi anemia group A protein modulates homologous repair of DNA double-strand breaks in mammalian cells. Carcinogenesis 26 (2005) 1731-1740
24. West S.C. Molecular views of recombination proteins and their control. Nat. Rev. Mol. Cell Biol. 4 (2003) 435-445
25. Thacker J. The RAD51 gene family, genetic instability and cancer. Cancer Lett. 219 (2005) 125-135
26. Bishop D.K., Ear U., Bhattacharyya A., Calderone C., Beckett M., Weichselbaum R.R., and Shinohara A. XRCC3 is required for assembly of Rad51 complexes in vivo. J. Biol. Chem. 273 (1998) 21482-21488
27. Gasior S.L., Olivares H., Ear U., Hari D.M., Weichselbaum R., and Bishop D.K. Assembly of RecA-like recombinases: distinct roles for mediator proteins in mitosis and meiosis. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 8411-8418
28. Liu Y.L., Masson J.Y., Shah R., O'Regan P., and West S.C. RAD51C is required for Holliday junction processing in mammalian cells. Science 303 (2004) 243-246
29. Medhurst A.L., Huber P.A.J., Waisfisz Q., de Winter J.P., and Mathew C.G. Direct interactions of the five known Fanconi anaemia proteins suggest a common functional pathway. Hum. Mol. Genet. 10 (2001) 423-429
30. Huber P.A.J., Medhurst A.L., Youssoufian H., and Mathew C.G. Investigation of Fanconi anemia protein interactions by yeast two-hybrid analysis. Biochem. Biophys. Res. Commun. 268 (2000) 73-77
31. Blom E., van de Vrugt H.J., de Vries Y., de Winter J.P., Arwert F., and Joenje H. Multiple TPR motifs characterize the Fanconi anemia FANCG protein. DNA Repair 3 (2004) 77-84
32. Gordon S.M., and Buchwald M. Fanconi anemia protein complex: mapping protein interactions in the yeast 2- and 3-hybrid systems. Blood 102 (2003) 136-141
33. Henry-Mowatt J., Jackson D., Masson J.Y., Johnson P.A., Clements P.M., Benson F.E., Thompson L.H., Takeda S., West S.C., and Caldecott K.W. XRCC3 and Rad51 modulate replication fork progression on damaged vertebrate chromosomes. Mol. Cell 11 (2003) 1109-1117
34. Johnson M.A., Bryant P.E., and Jones N.J. Isolation of camptothecin-sensitive Chinese hamster cell mutants: phenotypic heterogeneity within the ataxia telangiectasia-like XRCC8 (irs2) complementation group. Mutagenesis 15 (2000) 367-374
35. Liu N., Lamerdin J.E., Tebbs R.S., Schild D., Tucker J.D., Shen M.R., Brookman K.W., Siciliano M.J., Walter C.A., Fan W.F., Narayana L.S., Zhou Z.Q., Adamson A.W., Sorensen K.J., Chen D.J., Jones N.J., and Thompson L.H. XRCC2 and XRCC3, new human Rad51-family members, promote chromosome stability and protect against DNA cross-links and other damages. Mol. Cell 1 (1998) 783-793
36. Wilson J.B., Johnson M.A., Stuckert A.P., Trueman K.L., May S., Bryant P.E., Meyn R.E., D'Andrea A.D., and Jones N.J. The Chinese hamster FANCG/XRCC9 mutant NM3 fails to express the monoubiquitinated form of the FANCD2 protein, is hypersensitive to a range of DNA damaging agents and exhibits a normal level of spontaneous sister chromatid exchange. Carcinogenesis 22 (2001) 1939-1946
37. Qiao F.Y., Mi J., Wilson J.B., Zhi G., Bucheimer N.R., Jones N.J., and Kupfer G.M. Phosphorylation of Fanconi anemia (FA) complementation group G protein, FANCG, at serine 7 is important for function of the FA pathway. J. Biol. Chem. 279 (2004) 46035-46045
38. Waisfisz Q., de Winter J.P., Kruyt F.A.E., de Groot J., van der Weel L., Dijkmans L.M., Zhi Y., Arwert F., Scheper R.J., Youssoufian H., Hoatlin M.E., and Joenje H. A physical complex of the Fanconi anemia proteins FANCG/XRCC9 and FANCA. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 10320-10325
39. Nakanishi K., Moran A., Hays T., Kuang Y., Fox E., Garneau D., de Oca R.M., Grompe M., and D'Andrea A.D. Functional analysis of patient-derived mutations in the Fanconi anemia gene, FANCG/XRCC9. Exp. Hematol. 29 (2001) 842-849
40. de Winter J.P., van der Weel L., de Groot J., Stone S., Waisfisz Q., Arwert F., Scheper R.J., Kruyt F.A.E., Hoatlin M.E., and Joenje H. The Fanconi anemia protein FANCF forms a nuclear complex with FANCA, FANCC and FANCG. Hum. Mol. Genet. 9 (2000) 2665-2674
41. Das A.K., Cohen P.T.W., and Barford D. The structure of the tetratricopeptide repeats of protein phosphatase 5: implications for TPR-mediated protein-protein interactions. EMBO J. 17 (1998) 1192-1199
42. Blatch G.L., and Lassle M. The tetratricopeptide repeat: a structural motif mediating protein-protein interactions. Bioessays 21 (1999) 932-939
43. Meetei A.R., Sechi S., Wallisch M., Yang D.F., Young M.K., Joenje H., Hoatlin M.E., and Wang W.D. A multiprotein nuclear complex connects Fanconi anemia and Bloom syndrome. Mol. Cell. Biol. 23 (2003) 3417-3426
44. van de Vrugt H.J., Koomen M., Berns M.A.D., de Vries Y., Rooimans M.A., van der Weel L., Blom E., de Groot J., Schepers R.J., Stone S., Hoatlin M.E., Cheng N.C., Joenje H., and Arwert F. Characterization, expression and complex formation of the murine Fanconi anaemia gene product FancG. Genes Cells 7 (2002) 333-342
45. Garcia-Higuera I., Taniguchi T., Ganesan S., Meyn M.S., Timmers C., Hejna J., Grompe M., and D'Andrea A.D. Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway. Mol. Cell 7 (2001) 249-262
46. Masson J.Y., Stasiak A.Z., Stasiak A., Benson F.E., and West S.C. Complex formation by the human RAD51C and XRCC3 recombination repair proteins. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 8440-8446
47. Yuan S.S.F., Lee S.Y., Chen G., Song M.H., Tomlinson G.E., and Lee E. BRCA2 is required for ionizing radiation-induced assembly of RAD51 complex in vivo. Cancer Res. 59 (1999) 3547-3551
48. Digweed M., Rothe S., Demuth I., Scholz R., Schindler D., Stumm M., Grompe M., Jordan A., and Sperling K. Attenuation of the formation of DNA-repair foci containing RAD51 in Fanconi anaemia. Carcinogenesis 23 (2002) 1121-1126
49. Pichierri P., Averbeck D., and Rosselli F. DNA cross-link-dependent RAD50/MRE11/NBS1 subnuclear assembly requires the Fanconi anemia C protein. Hum. Mol. Genet. 11 (2002) 2531-2546
50. Godthelp B.C., Artwert F., Joenje H., and Zdzienicka M.Z. Impaired DNA damage-induced nuclear Rad51 foci formation uniquely characterizes Fanconi anemia group D1. Oncogene 21 (2002) 5002-5005
51. Godthelp B.C., Wiegant W.W., Waisfisz Q., Medhurst A.L., Arwert F., Joenje H., and Zdzienicka M.Z. Inducibility of nuclear Rad51 foci after DNA damage distinguishes all Fanconi anemia complementation groups from D1/BRCA2. Mut. Res. 594 (2006) 39-48
52. Kraakman-van der Zwet M., Overkamp W.J.I., van Lange R.E.E., Essers J., van Duijn-Goedhart A., Wiggers I., Swaminathan S., van Buul P.P.W., Errami A., Tan R.T.L., Jaspers N.G.J., Sharan S.K., Kanaar R., and Zdzienicka M.Z. Brca2 (XRCC11) deficiency results in radioresistant DNA synthesis and a higher frequency of spontaneous deletions. Mol. Cell. Biol. 22 (2002) 669-679
53. Jones N.J., Ellard S., Waters R., and Parry E.M. Cellular and chromosomal hypersensitivity to DNA cross-linking agents and topoisomerase inhibitors in the radiosensitive Chinese hamster irs mutants-phenotypic similarities to ataxia-telangiectasia and Fanconi's anemia cells. Carcinogenesis 14 (1993) 2487-2494
54. Godthelp B.C., Wiegant W.W., van Duijn-Goedhart A., Scharer O.D., van Buul P.P.W., Kanaar R., and Zdzienicka M.Z. Mammalian Rad51C contributes to DNA cross-link resistance, sister chromatid cohesion and genomic stability. Nucl. Acids Res. 30 (2002) 2172-2182
55. Tebbs R.S., Hinz J.M., Yamada N.A., Wilson J.B., Salazar E.P., Thomas C.B., Jones I.M., Jones N.J., and Thompson L.H. New insights into the Fanconi anemia pathway from an isogenic FancG hamster CHO mutant. DNA Repair 4 (2005) 11-22
56. Arlett C.F., and Harcourt S.A. Survey of radiosensitivity in a variety of human cell strains. Cancer Res. 40 (1980) 926-932
57. Teo I.A., and Arlett C.F. The response of a variety of human fibroblast cell strains to the lethal effects of alkylating-Agents. Carcinogenesis 3 (1982) 33-37
58. Ishida R., and Buchwald M. Susceptibility of Fanconi's anemia lymphoblasts to DNA-cross-linking and alkylating agents. Cancer Res. 42 (1982) 4000-4006
59. Dritschilo A., Brennan T., Weichselbaum R.R., and Mossman K.L. Response of human fibroblasts to low-dose rate gamma irradiation. Radiat. Res. 100 (1984) 387-395
60. Duckworth-Rysiecki G., and Taylor A.M.R. Effects of ionizing-radiation on cells from Fanconi's anemia patients. Cancer Res. 45 (1985) 416-420
61. Carreau M., Alon N., Bosnoyan-Collins L., Joenje H., and Buchwald M. Drug sensitivity spectra in Fanconi anemia lymphoblastoid cell lines of defined complementation groups. Mut. Res. DNA Repair 435 (1999) 103-109
62. Takata M., Sasaki M.S., Tachiiri S., Fukushima T., Sonoda E., Schild D., Thompson L.H., and Takeda S. Chromosome instability and defective recombinational repair in knockout mutants of the five Rad51 paralogs. Mol. Cell. Biol. 21 (2001) 2858-2866
63. Yamamoto K., Hirano S., Ishiai M., Morishima K., Kitao H., Namikoshi K., Kimura M., Matsushita N., Arakawa H., Buerstedde J.M., Komatsu K., Thompson L.H., and Takata M. Fanconi anemia protein FANCD2 promotes immunoglobulin gene conversion and DNA repair through a mechanism related to homologous recombination. Mol. Cell. Biol. 25 (2005) 34-43
64. Matsushita N., Kitao H., Ishiai M., Nagashima N., Hirano S., Okawa K., Ohta T., Yu D.S., McHugh P.J., Hickson I.D., Venkitaraman A.R., Kurumizaka H., and Takata M. A FancD2-monoubiquitin fusion reveals hidden functions of Fanconi anemia core complex in DNA repair. Mol. Cell 19 (2005) 841-847
65. McHugh P., Spanswick V., and Hartley J. Repair of DNA interstrand crosslinks: molecular mechanisms and clinical relevance. Lancet Oncol. 2 (2001) 483-490
66. Kuzminov A. DNA replication meets genetic exchange: chromosomal damage and its repair by homologous recombination. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 8461-8468
67. Sonoda E., Sasaki M.S., Buerstedde J.M., Bezzubova O., Shinohara A., Ogawa H., Takata M., Yamaguchi-Iwai Y., and Takeda S. Rad51-deficient vertebrate cells accumulate chromosomal breaks prior to cell death. EMBO J. 17 (1998) 598-608
68. Yamaguchi-Iwai Y., Sonoda E., Buerstedde J.M., Bezzubova O., Morrison C., Takata M., Shinohara A., and Takeda S. Homologous recombination, but not DNA repair, is reduced in vertebrate cells deficient in RAD52. Mol. Cell. Biol. 18 (1998) 6430-6435
69. Bezzubova O., Silbergleit A., Yamaguchi-Iwai Y., Takeda S., and Buerstedde J.M. Reduced X-ray resistance and homologous recombination frequencies in a RAD54(-/-) mutant of the chicken DT40 cell line. Cell 89 (1997) 185-193
70. Essers J., Hendriks R.W., Swagemakers S.M.A., Troelstra C., deWit J., Bootsma D., Hoeijmakers J.H.J., and Kanaar R. Disruption of mouse RAD54 reduces ionizing radiation resistance. Cell 89 (1997) 195-204
71. Rijkers T., Van den Ouweland J., Morolli B., Rolink A.G., Baarends W.M., Van Sloun P.P.H., Lohman P.H.M., and Pastink A. Targeted inactivation of mouse RAD52 reduces homologous recombination but not resistance to ionizing radiation. Mol. Cell. Biol. 18 (1998) 6423-6429
72. Deans B., Griffin C.S., Maconochie M., and Thacker J. XRCC2 is required for genetic stability, embryonic neurogenesis and viability in mice. EMBO J. 19 (2000) 6675-6685
73. Shu Z.G., Smith S., Wang L.J., Rice M.C., and Kmiec E.B. Disruption of muREC2/RAD51L1 in mice results in early embryonic lethality which can be partially rescued in a p53(-/-) background. Mol. Cell. Biol. 19 (1999) 8686-8693
74. Pittman D.L., and Schimenti J.C. Midgestation lethality in mice deficient for the RecA-related gene, Rad51D/Rad51L3. Genesis 26 (2000) 167-173
75. Ludwig T., Chapman D.L., Papaioannou V.E., and Efstratiadis A. Targeted mutations of breast cancer susceptibility gene homologs in mice: lethal phenotypes of Brca1, Brca2, Brca1/Brca2, Brca1/p53, and Brca2/p53 nullizygous embryos. Genes Dev. 11 (1997) 1226-1241
76. Connor F., Bertwistle D., Mee P.J., Ross G.M., Swift S., Grigorieva E., Tybulewicz V.L.J., and Ashworth A. Tumorigenesis and a DNA repair defect in mice with a truncating Brca2 mutation. Nat. Genet. 17 (1997) 423-430
77. Hirsch B., Shimamura A., Moreau L., Baldinger S., Hag-alshiekh M., Bostrom B., Sencer S., and D'Andrea A.D. Association of biallelic BRCA2/FANCD1 mutations with spontaneous chromosomal instability and solid tumors of childhood. Blood 103 (2004) 2554-2559
78. Wagner J.E., Tolar J., Levran O., Scholl T., Deffenbaugh A., Satagopan J., Ben-Porat L., Mah K., Batish S.D., Kutler D.I., MacMillan M.L., Hanenberg H., and Auerbach A.D. Germline mutations in BRCA2: shared genetic susceptibility to breast cancer, early onset leukemia, and Fanconi anemia. Blood 103 (2004) 3226-3229
79. Chen M., Tomkins D.J., Auerbach W., McKerlie C., Youssoufian H., Liu L., Gan O., Carreau M., Auerbach A., Groves T., Guidos C.J., Freedman M.H., Cross J., Percy D.H., Dick J.E., Joyner A.L., and Buchwald M. Inactivation of FAC in mice produces inducible chromosomal instability and reduced fertility reminiscent of Fanconi anaemia. Nat. Genet. 12 (1996) 448-451
80. Cheng N.C., van de Vrugt H.J., van der Valk M.A., Oostra A.B., Krimpenfort P., de Vries Y., Joenje H., Berns A., and Arwert F. Mice with a targeted disruption of the Fanconi anemia homolog FancA. Hum. Mol. Genet. 9 (2000) 1805-1811
81. Yang Y., Kuang Y.N., De Oca R.M., Hays T., Moreau L., Lu N.F., Seed B., and D'Andrea A.D. Targeted disruption of the murine Fanconi anemia gene, FancG/Xrcc9. Blood 98 (2001) 3435-3440
82. Patel K.J., Yu V., Lee H.S., Corcoran A., Thistlethwaite F.C., Evans M.J., Colledge W.H., Friedman L.S., Ponder B.A.J., and Venkitaraman A.R. Involvement of BRCA2 in DNA repair. Mol. Cell 1 (1998) 347-357
83. Faivre L., Guardiola P., Lewis C., Dokal I., Ebell W., Zatterale Z., Altay C., Poole J., Stones D., Kwee M.L., van Weel-Sipman M., Havenga C., Morgan N., de Winter J., Digweed M., Savoia A., Pronk J., de Ravel T., Jansen S., Joenje H., Gluckman E., and Mathew C.G. Association of complementation group and mutation type with clinical outcome in Fanconi anemia. Blood 96 (2000) 4064-4070